{"id":50005,"date":"2022-10-24T22:02:06","date_gmt":"2022-10-24T20:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/"},"modified":"2022-10-24T22:02:06","modified_gmt":"2022-10-24T20:02:06","slug":"oragenics-to-participate-in-the-2022-bioflorida-annual-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/","title":{"rendered":"Oragenics to Participate in the 2022 BioFlorida Annual Conference"},"content":{"rendered":"
\n

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (\u201cOragenics\u201d or the \u201cCompany\u201d),<\/b> a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami.\n<\/p>\n

<\/a><\/p>\n

\nKim Murphy, President and CEO, will be participating on a panel titled \u201cBioTrends: Learning from the Pandemic: The Fight Against Infectious Diseases\u201d on Thursday, November 3 from 2:05 p.m. to 3:05 p.m.\n<\/p>\n\n\n\n\n\n
\n

\nPanel:<\/b>\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\nBioTrends: Learning from the Pandemic: The Fight Against Infectious Diseases\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:<\/b>\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\nThursday, November 3, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:<\/b>\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\n2:05 p.m. Eastern Time\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nLocation:<\/b>\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\u00a0<\/td>\n\n

\nHyatt Regency Miami\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nMs. Murphy will also be participating in BioFlorida\u2019s one-on-one investor and business development meetings. Please contact LHA Investor Relations<\/a> to schedule a meeting.\n<\/p>\n

\nAbout Oragenics, Inc.<\/b>\n<\/p>\n

\nOragenics, Inc. is a development-stage company dedicated to fighting infectious diseases, including those caused by coronaviruses and multidrug-resistant organisms. Its lead product is NT-CoV2-1, an intranasal vaccine candidate to prevent COVID-19 and variants of the SARS-CoV-2 virus. The NT-CoV2-1 program leverages coronavirus spike protein research licensed from the NIH and the NRC with a focus on reducing viral transmission and offering a more patient-friendly intranasal administration. Its lantibiotics program features a novel class of antibiotics against bacteria that have developed resistance to commercial antibiotics. For more information about Oragenics, please visit www.oragenics.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nOragenics, Inc.<\/b>
Michael Sullivan, Chief Financial Officer
\n
813-286-7900
\n
msullivan@oragenics.com<\/a>\n<\/p>\n

\nLHA Investor Relations<\/b>
Tirth T. Patel
\n
212-201-6614
\n
tpatel@lhai.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (\u201cOragenics\u201d or the \u201cCompany\u201d), a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami. Kim Murphy, President and CEO, will be participating on a panel titled \u201cBioTrends: Learning from the Pandemic: The Fight … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50005","6":"format-standard","7":"category-industry"},"yoast_head":"\nOragenics to Participate in the 2022 BioFlorida Annual Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oragenics to Participate in the 2022 BioFlorida Annual Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (\u201cOragenics\u201d or the \u201cCompany\u201d), a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami. Kim Murphy, President and CEO, will be participating on a panel titled \u201cBioTrends: Learning from the Pandemic: The Fight ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T20:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221024005965\/en\/232000\/21\/O_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Oragenics to Participate in the 2022 BioFlorida Annual Conference\",\"datePublished\":\"2022-10-24T20:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/\"},\"wordCount\":247,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005965\\\/en\\\/232000\\\/21\\\/O_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/\",\"name\":\"Oragenics to Participate in the 2022 BioFlorida Annual Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005965\\\/en\\\/232000\\\/21\\\/O_logo.jpg\",\"datePublished\":\"2022-10-24T20:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005965\\\/en\\\/232000\\\/21\\\/O_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005965\\\/en\\\/232000\\\/21\\\/O_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oragenics to Participate in the 2022 BioFlorida Annual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oragenics to Participate in the 2022 BioFlorida Annual Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Oragenics to Participate in the 2022 BioFlorida Annual Conference - Pharma Trend","og_description":"TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (\u201cOragenics\u201d or the \u201cCompany\u201d), a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami. Kim Murphy, President and CEO, will be participating on a panel titled \u201cBioTrends: Learning from the Pandemic: The Fight ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-24T20:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221024005965\/en\/232000\/21\/O_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Oragenics to Participate in the 2022 BioFlorida Annual Conference","datePublished":"2022-10-24T20:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/"},"wordCount":247,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005965\/en\/232000\/21\/O_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/","url":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/","name":"Oragenics to Participate in the 2022 BioFlorida Annual Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005965\/en\/232000\/21\/O_logo.jpg","datePublished":"2022-10-24T20:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221024005965\/en\/232000\/21\/O_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221024005965\/en\/232000\/21\/O_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/oragenics-to-participate-in-the-2022-bioflorida-annual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Oragenics to Participate in the 2022 BioFlorida Annual Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50005"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50005\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}